| Product Code: ETC9515336 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Suriname Lumasiran Market Overview |
3.1 Suriname Country Macro Economic Indicators |
3.2 Suriname Lumasiran Market Revenues & Volume, 2021 & 2031F |
3.3 Suriname Lumasiran Market - Industry Life Cycle |
3.4 Suriname Lumasiran Market - Porter's Five Forces |
3.5 Suriname Lumasiran Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Suriname Lumasiran Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Suriname Lumasiran Market Revenues & Volume Share, By Dosage form, 2021 & 2031F |
3.8 Suriname Lumasiran Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 Suriname Lumasiran Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.10 Suriname Lumasiran Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Suriname Lumasiran Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of rare diseases in Suriname |
4.2.2 Growing awareness and adoption of advanced therapies in the healthcare sector |
4.2.3 Favorable government regulations and policies supporting the development and use of innovative treatments |
4.3 Market Restraints |
4.3.1 High cost associated with lumasiran treatment |
4.3.2 Limited healthcare infrastructure and resources in Suriname |
4.3.3 Challenges in patient access and affordability of the treatment |
5 Suriname Lumasiran Market Trends |
6 Suriname Lumasiran Market, By Types |
6.1 Suriname Lumasiran Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Suriname Lumasiran Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 Suriname Lumasiran Market Revenues & Volume, By Miscellaneous Metabolic Agents, 2021- 2031F |
6.1.4 Suriname Lumasiran Market Revenues & Volume, By others, 2021- 2031F |
6.2 Suriname Lumasiran Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Suriname Lumasiran Market Revenues & Volume, By Primary Hyperoxaluria, 2021- 2031F |
6.2.3 Suriname Lumasiran Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Suriname Lumasiran Market, By Dosage form |
6.3.1 Overview and Analysis |
6.3.2 Suriname Lumasiran Market Revenues & Volume, By Injection, 2021- 2031F |
6.3.3 Suriname Lumasiran Market Revenues & Volume, By Solution, 2021- 2031F |
6.4 Suriname Lumasiran Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 Suriname Lumasiran Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.4.3 Suriname Lumasiran Market Revenues & Volume, By Demographic, 2021- 2031F |
6.4.4 Suriname Lumasiran Market Revenues & Volume, By Adult, 2021- 2031F |
6.4.5 Suriname Lumasiran Market Revenues & Volume, By Pediatric, 2021- 2031F |
6.5 Suriname Lumasiran Market, By End-Users |
6.5.1 Overview and Analysis |
6.5.2 Suriname Lumasiran Market Revenues & Volume, By Clinics, 2021- 2031F |
6.5.3 Suriname Lumasiran Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.4 Suriname Lumasiran Market Revenues & Volume, By Diagnostic center, 2021- 2031F |
6.6 Suriname Lumasiran Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 Suriname Lumasiran Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.6.3 Suriname Lumasiran Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.6.4 Suriname Lumasiran Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
7 Suriname Lumasiran Market Import-Export Trade Statistics |
7.1 Suriname Lumasiran Market Export to Major Countries |
7.2 Suriname Lumasiran Market Imports from Major Countries |
8 Suriname Lumasiran Market Key Performance Indicators |
8.1 Number of patients diagnosed with the specific rare disease targeted by lumasiran |
8.2 Rate of adoption of advanced therapies in the healthcare system |
8.3 Level of government funding and support for rare disease treatments |
8.4 Patient adherence and compliance to the lumasiran treatment regimen |
8.5 Research and development investment in rare disease therapies |
9 Suriname Lumasiran Market - Opportunity Assessment |
9.1 Suriname Lumasiran Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Suriname Lumasiran Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Suriname Lumasiran Market Opportunity Assessment, By Dosage form, 2021 & 2031F |
9.4 Suriname Lumasiran Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 Suriname Lumasiran Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.6 Suriname Lumasiran Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Suriname Lumasiran Market - Competitive Landscape |
10.1 Suriname Lumasiran Market Revenue Share, By Companies, 2024 |
10.2 Suriname Lumasiran Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here